PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate to clean stainless steel equipment, resilient floors, walls, and painted surfaces. The company also provides Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial formulation that is used against bacteria, viruses, yeasts, and molds. PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California.
The current price of PURE is $0.1 USD — it has decreased by -3.06% in the past 24 hours. Watch Pure Bioscience stock price performance more closely on the chart.
What is Pure Bioscience stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Pure Bioscience stocks are traded under the ticker PURE.
Is Pure Bioscience stock price growing?▼
PURE stock has risen by +5.67% compared to the previous week, the month change is a +58.5% rise, over the last year Pure Bioscience has showed a +35.86% increase.
What is Pure Bioscience market cap?▼
Today Pure Bioscience has the market capitalization of 10.64M
What were Pure Bioscience earnings last quarter?▼
PURE earnings for the last quarter are -0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Pure Bioscience revenue for the last year?▼
Pure Bioscience revenue for the last year amounts to 4.4M USD.
What is Pure Bioscience net income for the last year?▼
PURE net income for the last year is -4.8M USD.
How many employees does Pure Bioscience have?▼
As of April 04, 2026, the company has 11 employees.
In which sector is Pure Bioscience located?▼
Pure Bioscience operates in the Consumer Staples sector.
When did Pure Bioscience complete a stock split?▼
The last stock split for Pure Bioscience was on August 15, 2012 with a ratio of 1:8.